Why Dementia Tech Needs Privacy and Consent Safeguards

Dementia technology promises to improve safety, independence, and quality of life for millions of people living with cognitive decline.

Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.

Dementia tech sits at the center of this dementia and brain health question.

Dementia technology promises to improve safety, independence, and quality of life for millions of people living with cognitive decline. Wearable devices track location, medication apps send reminders, and monitoring systems alert caregivers to falls or wandering. But each of these innovations collects intimate data—movement patterns, medication histories, daily routines, bathroom visits, sleep schedules—about people who may not fully understand what they’re agreeing to and often cannot withdraw consent later. This is why dementia tech specifically needs robust privacy safeguards and informed consent frameworks: people with dementia are among the most vulnerable populations when it comes to data misuse, and the consequences of privacy breaches extend beyond identity theft to include exploitation, loss of autonomy, and deepened isolation.

The stakes are particularly high because dementia patients often lack decision-making capacity. A 2022 analysis of consent practices in digital health found that many dementia care apps required only a single caregiver’s consent, with no mechanism to assess whether the person using the device actually understood what data was being collected or how it would be used. When a product requires location tracking to prevent wandering, users cannot opt out because the device’s core function depends on surveillance. When a memory-support app trains on conversations, every interaction becomes data for optimization—but the person speaking may not retain the memory of having agreed to it.

Table of Contents

What Privacy Risks Do Dementia Technologies Present?

Dementia tech collects data that would be considered highly sensitive in any other context. Location data from GPS-enabled wearables can reveal whether someone visited a bar, a church, a mental health clinic, or a romantic partner’s home. Medication management apps log exact dosing times and drug names. Voice assistants and reminder systems record conversations and daily activities. Sleep-tracking devices detail night-time bathroom visits. In aggregate, this data paints a detailed picture of someone’s health status, habits, relationships, and vulnerabilities—information that could be used to manipulate, exploit, or discriminate against them. The privacy risks multiply when these systems integrate with broader ecosystems.

A person’s location data might be sold to insurance companies, affecting their premiums. Medication patterns could reveal a diagnosis that the person with dementia hasn’t disclosed to employers or potential partners. Voice recordings might be used for secondary AI training without explicit understanding or consent. A 2021 investigation by privacy advocates found that several popular senior care apps were sharing location and behavioral data with data brokers without clear disclosure, creating chains of custody that made it nearly impossible for users to know where their information had traveled or who could access it. Device companies themselves may not have strong incentives to protect this data. If a dementia care device maker is later acquired or goes bankrupt, patient data could be sold off as a business asset. If a company faces a data breach, the notification letter arrives at the registered account holder (usually a caregiver), but the person whose data was compromised may never learn they were exposed. This misalignment between who controls the data and who experiences the consequences is a core privacy vulnerability in dementia tech.

What Privacy Risks Do Dementia Technologies Present?

Obtaining meaningful informed consent from someone with dementia is legally and ethically complex. Dementia affects memory, comprehension, and the ability to weigh risks and benefits—exactly the capacities required for informed consent. A person with mid-stage dementia might agree to location tracking when asked by their adult child, forget that they agreed, and then experience the device as surveillance and violation of privacy. They cannot later withdraw consent because they have no memory of having given it. In some cases, people with early-stage dementia understand the privacy implications clearly but lose that understanding months later, creating a situation where the original consent is no longer ethically valid but can never be re-established. Current consent frameworks often ignore these realities. Most health apps require a single signature or one-click agreement—appropriate for a cognitively intact user but inadequate for dementia.

Some apps do allow family members to consent on behalf of the person with dementia, but this raises its own ethical questions. A caregiver might choose extensive monitoring out of fear of liability, overriding the person with dementia’s earlier preferences. An adult child might consent to location tracking to prevent wandering, but the person with dementia experiences it as control. The assumption that one person can consent for another, especially in a family context with potential conflicts of interest, masks important ethical gray areas. A limitation of consent-based privacy frameworks is that they assume the person affected can meaningfully opt out. But opting out of dementia tech often means sacrificing safety features or care coordination. If someone refuses a medication reminder app, are they neglecting their health? If they resist location monitoring, are they at risk? Privacy and safety become positioned as trade-offs, with the vulnerable person’s autonomy deprioritized. True consent frameworks need to build privacy as a default, not an optional extra that people give up to access care.

Data Collection Practices in Top 10 Dementia Care AppsLocation Tracking80%Medication Logging70%Voice Recording50%Behavioral Analytics65%Third-Party Data Sharing75%Source: Analysis of app privacy policies and terms of service (2024-2025)

Real-World Examples of Privacy Failures in Dementia and Senior Care Tech

In 2020, a family sued a senior care facility after discovering that the facility had installed hidden cameras in a resident’s room to monitor wandering behavior. The facility had never disclosed the cameras to the resident or her family, arguing that security and dementia management justified covert surveillance. The case highlighted how institutional logic can override individual privacy rights when safety is the stated priority. The resident had advanced dementia and could not consent, but she was still the person whose privacy was violated. A medication management app widely used in assisted living and memory care facilities was found to be collecting not just medication adherence data but keystroke patterns, device usage times, and location data whenever the app was accessed.

The company’s privacy policy was technically disclosed to caregivers but was written in technical language that most caregivers did not fully understand. When families requested their data or asked for deletion, the company explained that the data was needed for “system optimization and service improvement”—standard tech industry language that kept data flowing indefinitely. A wearable device marketed for fall detection and wandering prevention included a feature that automatically shared the wearer’s location with a central monitoring center and any designated family members. There was no granular control: a person could not allow family to see location but disable the central monitoring, or allow daytime tracking but disable nighttime tracking. The device was programmed with the assumption that comprehensive surveillance was safe and necessary, and any attempt to weaken it was framed as a safety risk. For a person with dementia in the early stages, this all-or-nothing design meant privacy could only be protected by rejecting a tool that genuinely improved safety—a false choice.

Real-World Examples of Privacy Failures in Dementia and Senior Care Tech

Building Privacy Into Dementia Technology Design

Privacy-first dementia tech starts with minimizing data collection rather than maximizing it. A fall detection system does not need to know where someone fell, only that a fall occurred and a caregiver should check on them. A medication reminder app does not need to know why someone takes a medication, track their location, or monitor how long they spend getting pills—it only needs to send a reminder and confirm adherence. Too much dementia tech collects more data than is necessary for its stated function, creating privacy risk without additional clinical benefit. Granular consent and control mechanisms are essential. Rather than a single yes-or-no agreement to data sharing, dementia tech should allow caregivers and patients (when capable) to choose what data is collected, who can access it, and how long it is retained.

A medication reminder should have separate toggles for medication reminders, adherence logging, and data sharing with doctors. Location tracking should offer choices: real-time tracking for designated caregivers only, location history only when requested, or location sharing only for emergencies. These options require more complex design work, but they respect the different comfort levels and privacy needs within families. The tradeoff is that more granular controls sometimes require more caregiver engagement and decision-making—caregivers need clear guidance and default settings that prioritize privacy unless they actively choose otherwise. Transparency about data use and ownership is a starting point but not sufficient. People and their families need to understand not only that data is collected but what happens to it: Is it sold to third parties? Retained after the person stops using the device? Used for algorithm training? Could it be subpoenaed in a legal proceeding? Buried in privacy policies, these details are rarely reviewed. Dementia tech companies should provide plain-language summaries of data practices and require periodic affirmation of consent as a device continues to be used, especially if the person with dementia’s capacity changes.

The Limits of Current Regulations and Safeguards

HIPAA, the main U.S. federal health privacy law, provides important protections for health information but has significant gaps in the dementia tech space. HIPAA applies primarily to covered entities—doctors, hospitals, insurers—and their business associates. A wearable device sold directly to consumers, a family-managed location tracker, or a reminder app from a small startup may fall outside HIPAA’s scope entirely. Even when HIPAA applies, it focuses on preventing unauthorized access and requires notification of breaches—but it does not prevent a company from collecting more data than necessary or sharing data with a long chain of vendors. A person’s location history might be HIPAA-compliant to share with a medical provider but still represent a serious privacy exposure. State-level privacy laws like California’s Consumer Privacy Act (CCPA) require transparency and allow consumers to access and delete their data.

But CCPA has exceptions for employee data and small businesses, and the deletion right does not apply if data is necessary for the service. A dementia care company could argue that location history is necessary for fall detection or wandering prevention and therefore cannot be deleted. For someone with dementia, the ability to request their own data deletion is also complicated by the fact that they may lack the cognitive capacity to make that request or may have already forgotten why they wanted the data deleted. A significant limitation is that regulations lag behind technology. AI-powered monitoring systems, predictive algorithms that forecast health decline, and voice-analysis tools that detect cognitive changes are becoming standard in dementia tech. But most of these systems operate in regulatory gray zones. If an AI system analyzes someone’s speech patterns to detect dementia progression and stores those voice recordings, is that health information subject to HIPAA? Is the algorithmic analysis itself subject to any privacy standard? These questions remain largely unanswered, leaving vulnerable people as test cases for new technologies that companies deploy and refine as they go.

The Limits of Current Regulations and Safeguards

Family and Caregiver Responsibilities in Data Protection

Family caregivers are often the ones making technology decisions for people with dementia, but many are not equipped to evaluate privacy risks. A caregiver choosing a monitoring device might focus on immediate safety benefits without considering long-term data exposure or future scenarios where that data could be misused. Caregivers should ask specific questions before adopting dementia tech: What data is collected? Who owns the data? Can the data be deleted if the person stops using the device? What happens if the company is acquired or goes out of business? How is data secured? Is it encrypted in transit and at rest? These questions require digging past marketing materials and privacy policies into technical documentation or direct conversations with the company. Caregivers also have a responsibility to honor the preferences of the person with dementia when those preferences can be known.

If someone with early-stage dementia clearly states that they do not want location tracking despite fall risk, that preference should be respected even if it means choosing lower-tech alternatives or accepting higher risk. If someone objects to a monitoring device even after it is explained to them multiple times, caregivers should explore why and whether that objection reflects their true values and autonomy. The comparison is instructive: we do not override the privacy wishes of cognitively intact people for their own safety, yet we frequently do so for people with dementia. Caregivers can push back against this pattern by seeking technologies that preserve autonomy and respect explicit or earlier-expressed preferences even when safety arguments are compelling.

The Future of Privacy-First Dementia Care Tech

A promising direction is privacy-by-design development, where dementia tech companies build privacy protections into products from the start rather than adding them after launch. Some innovative platforms are testing edge computing—processing data on the device itself rather than sending it to cloud servers—so that a fall detection system can work locally without transmitting location data to a central server. Others are experimenting with federated learning, where a device learns and improves without sending raw data off-device. These approaches are more technically complex and sometimes less efficient than centralized data collection, but they meaningfully reduce privacy exposure while maintaining function.

As the population ages and dementia tech becomes more widespread, advocacy and policy efforts are emerging to establish stronger baseline protections. Some organizations are developing consent frameworks specifically designed for people with cognitive impairment, emphasizing easier understanding, ongoing re-consent, and the ability to modify or withdraw consent. Others are calling for regulation of dementia-specific technology, similar to medical device oversight, to ensure that products undergo privacy audits before they reach vulnerable users. The dementia tech market is still young, and early choices about privacy standards may shape the field for decades. Families and caregivers who demand privacy safeguards, demand transparency, and choose products that respect autonomy can influence what becomes standard practice.

Conclusion

Privacy safeguards in dementia technology are not luxuries or barriers to innovation—they are essential protections for a vulnerable population whose data is particularly sensitive and whose ability to control it is compromised by their condition. Meaningful consent frameworks, minimal data collection, granular controls, and transparent practices require more thoughtful technology design than current industry standards often demand, but they are necessary to prevent exploitation and preserve autonomy in dementia care.

The path forward requires engagement from multiple stakeholders: technology companies must prioritize privacy and meaningful consent; regulators must catch up to the speed of innovation in dementia tech; caregivers must ask hard questions and choose products thoughtfully; and advocates must push for stronger protections for a population that cannot advocate for itself. Dementia care technology can be both safe and privacy-respecting, but only if privacy is treated as fundamental, not optional.


You Might Also Like

For more, see National Institute on Aging.